Affirms FY25 revenue view of $5.905B-$5.955B, consensus $5.93B. The company states: “Members of Encompass Health (EHC) Corporation’s senior management team are scheduled to meet with investors and analysts at various meetings on December 2, 2025 and December 3, 2025. The Company reiterates as of the date hereof its guidance previously reported in the Current Report on Form 8-K, dated October 29, 2025, and during the Company’s earnings conference call held on October 30, 2025. Accordingly, the Company continues to expect the following full-year 2025 ranges: *Net operating revenue of $5,905 million to $5,955 million; Adjusted EBITDA of $1,235 million to $1,255 million; and Adjusted earnings per share from continuing operations attributable to Encompass Health of $5.22 to $5.37.”
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EHC:
- Encompass Health and Vanderbilt Health to build 40-bed rehabilitation hospital
- Encompass Health plans to build 50-bed rehabilitation hospital in Indiana
- Encompass Health’s Earnings Call Highlights Growth and Optimism
- Encompass Health Reports Strong Q3 2025 Earnings
- Encompass Health price target raised to $150 from $141 at Barclays